177Lu-edotreotide

lutetium-177-edotreotide · ITM Solucin GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-edotreotide, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients [Phase 3]